The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth
Keywords
Opioid use disorder (OUD)
Medication for opioid use disorder (MOUD)
COVID-19
Buprenorphine
Telehealth
Addiction
Treatment
Cited by (0)
- 1
Mailing address: 5722 Outer Loop, Louisville, KY 40219, United States of America.
- 2
Mailing address: 550 S. Jackson St., Louisville, KY 40202, United States of America.
© 2021 Elsevier Inc. All rights reserved.